AMENDMENT #1

THIS AMENDMENT #1 (the “Amendment”) to the Transaction Documents (as defined below) is entered into as of June 18, 2026 (the “Effective Date”), by and between IGC Pharma, Inc., a Maryland corporation (the “Company”), and FirstFire Global Opportunities Fund, LLC, a Delaware limited liability company (the “Holder”) (collectively the “Parties”).

BACKGROUND

A. The Company and Holder are the parties to that certain securities purchase agreement dated on April 10, 2026 (the “Purchase Agreement”), pursuant to which the Company issued to Holder that certain promissory note in the original principal amount of $346,910.00 (the “Note”, and collectively with the Purchase Agreement and ancillary documentation entered into between the Parties in connection therewith, the “Transaction Documents”).

B. The Parties desire to amend the Transaction Documents as set forth expressly below.

NOW THEREFORE, in consideration of the execution and delivery of the Amendment and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Parties agree as follows:

…

Certain identified information has been excluded from the exhibit because it is both (i) not material and (ii) is the type of information that the registrant treats as private or confidential. Double asterisks denote omissions.

Exhibit 10.7

FIRST AMENDMENT

to the

LICENSE AGREEMENT

This First Amendment to the License Agreement(this “Amendment”) is entered into as of August 14, 2026 (the “Amendment Date”) by and between Ascendant Health Sciences Limited, a company incorporated under the laws of the Cayman Islands with an address of Palm Grove Unit 4, 265 Smith Road, George Town, Grand Cayman KY1-9006, Cayman Islands (“Ascendant”), and Cue Biopharma, Inc., a company incorporated in Delaware with an address of 40 Guest Street, Boston, Massachusetts 02135, United States (“Cue”). Ascendant and Cue are each referred to herein by name or as a “Party” or, collectively, as the “Parties”.

RECITALS:

WHEREAS, Cue and Ascendant are Parties to that certain License Agreement dated April 30, 2026 (the “Original Agreement” and together with this Amendment, the “Agreement”).

WHEREAS, the Parties desire, through this Amendment, to amend the Agreement according to the terms set forth below.

NOW, THEREFORE, in consideration of the foregoing premises and the mutual covenants herein contained, the Parties hereby agree as follows:

1.

Definitions. Capitalized terms used but not defined in this Amendment shall have the meanings assigned to such terms in the Agreement.

2.

Amendments.

2.1.

…

SEPARATION AND RELEASE OF CLAIMS AGREEMENT

This Separation and Release of Claims Agreement (the “Agreement”) is entered into by and between Cue Biopharma, Inc. (the “Company”) and Lucinda Warren (“Executive”) (together, the “Parties”).

WHEREAS, the Company and Executive are parties to that certain Amended and Restated Executive Employment Agreement effective as of March 27, 2026 (the “Employment Agreement”), pursuant to which Executive serves as the Company’s Interim President and Chief Executive Officer and Chief Financial & Business Officer;

WHEREAS, Executive’s last day of employment with the Company will be May 4, 2026 (the “Separation Date”);

WHEREAS, the Parties wish to establish mutually agreeable terms for Executive’s separation from the Company; and

WHEREAS, the Parties agree that the benefits and rights set forth in this Agreement shall be the exclusive benefits and rights due Executive.

NOW, THEREFORE, in consideration of the mutual covenants and agreements contained herein, and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Parties hereby agree as follows:

1.

…

CUE BIOPHARMA, INC.

EXECUTIVE EMPLOYMENT AGREEMENT

This Executive Employment Agreement (the “Agreement”) is made by and between Cue Biopharma, Inc., a Delaware corporation (“Cue” or the “Company”), and Shao-Lee Lin (“Executive,” and together with Cue, the “Parties”).

WHEREAS, the Company and Executive desire to enter into this Agreement to set forth the conditions under which Executive will be employed by the Company.

NOW, THEREFORE, in consideration of the foregoing, of the mutual promises contained herein and of other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Parties hereby agree as follows:

1.

POSITION AND DUTIES.

(a)

As of the Effective Date (as defined below), Cue shall employ Executive as its President and CEO. Executive shall have such duties and authority commensurate with the position of President and CEO, and such other duties commensurate with her position that may be assigned by the Board of Directors of Cue (the “Board”).

(b)

During the Term of Employment (as defined below), the Company will use its best efforts to cause Executive to be nominated for election to the Board at each annual meeting of stockholders and shall recommend that stockholders vote in favor of such election and Executive, upon being duly elected, shall serve as a member of the Board for no additional compensation.

(c)

…

Certain identified information has been excluded from the exhibit because it is both (i) not material and (ii) is the type of information that the registrant treats as private or confidential. Double asterisks denote omissions.

Exhibit 10.4

LICENSE AGREEMENT

by and between

ASCENDANT HEALTH SCIENCES LIMITED

and

CUE BIOPHARMA, INC.

dated as of April 30, 2026

LICENSE AGREEMENT

This License Agreement(this “Agreement”) is entered into as of April 30, 2026 (the “Effective Date”) by and between Ascendant Health Sciences Limited, a company incorporated under the laws of the Cayman Islands with an address of Palm Grove Unit 4, 265 Smith Road, George Town, Grand Cayman KY1-9006, Cayman Islands (“Ascendant”), and Cue Biopharma, Inc., a company incorporated in Delaware with an address of 40 Guest Street, Boston, Massachusetts 02135, United States (“Cue”). Ascendant and Cue are each referred to herein by name or as a “Party” or, collectively, as the “Parties”.

Recitals

Whereas, Ascendant is a biopharmaceutical company engaged in the research, development, manufacture and commercialization of human therapeutic products;

Whereas, Ascendant and its Affiliates have developed a certain humanized IgG1 monoclonal antibody that has anti-IgE effect, designed to neutralize IgE and inhibit its production;

Whereas, Cue is a biopharmaceutical company engaged in the research, development, manufacture and commercialization of human therapeutic products.

…

MASTECHDIGITAL,INC.

2008STOCKINCENTIVEPLAN

(asamendedandrestated)

RESTRICTEDSTOCK UNIT (RSU) AGREEMENT

THIS RESTRICTED STOCK UNIT (RSU) AGREEMENT (this “Agreement”) is made as of the date set forth on Schedule A hereto (the “Grant Date”) by and between Mastech Digital, Inc., a Pennsylvania corporation (the “Corporation”), and the person named on Schedule A hereto (the “Grantee”).

WHEREAS, Grantee is a valuable employee of the Corporation or one of its subsidiaries (each, an “Affiliate”) and the Corporation considers it desirable and in its best interest that Grantee be given an inducement to acquire a proprietary interest in the Corporation and an incentive to advance the interests of the Corporation by granting the Grantee restricted stock units representing the right to receive shares of common stock, par value $.01 per share, of the Corporation (the “Stock”); and

WHEREAS, the Corporation has adopted the 2008 Stock Incentive Plan (the "Plan") under which the Corporation may grant restricted stock units to key employees of the Corporation subject to restrictions set forth in the Plan and this Agreement.

…

SECRETARY’S CERTIFIED EXTRACT FROM BOARD MINUTES

AND WRITTEN DESCRIPTION OF SUBSEQUENT MODIFICATION

TO SHARE COMPENSATION ARRANGEMENT

The undersigned, being the duly elected and acting Secretary of ESG Inc., a Nevada corporation (the “Company”), hereby certifies as follows:

1. October 17, 2024 Share Compensation Arrangement

The following is a true and correct extract of the action taken by the Board of Directors of the Company at a duly called meeting held on October 17, 2024, as reflected in the official minutes of the Company:

Upon motion duly made, seconded and unanimously carried, the Board of Directors approved annual stock-based compensation as follows:

	1)	John Wallace, as Chairman of the Board — shares of the Company’s common stock valued at $50,000 annually;

	2)	Cathy Fleming, Mark Hemmann, Neal Naito and Thomas Yang, as members of the Board — shares of the Company’s common stock valued at $36,000 annually for each director;

…

** **

SIDE AGREEMENT REGARDING INTERIM MANAGEMENT

OF

TEXAS LOAD HOUSE, LLC

This Side Agreement Regarding Interim Management (this “Side Agreement”) is entered into effective as of the 14th day of July, 2026 (the “Side Agreement Effective Date”), by and between 10NetZero, Inc., a Delaware corporation (“10NZ”), and Big Digital Energy, Inc. (“BDE”), who together constitute all of the Members of Texas Load House, LLC, a Texas limited liability company (the “Company”). 10NZ and BDE are referred to herein each as a “Party” and together as the “Parties.”

RECITALS

A. The Parties are parties to that certain Binding Letter of Intent — Cowtown Site Joint Venture dated May 20, 2026 (the “LOI”). Section 5.1 of the LOI provides that 10NZ shall serve as Manager and day-to-day Operator of the Company and that major decisions shall require the consent of both Members. Section 17 of the LOI provides that the governance terms of the LOI are fixed and not subject to renegotiation in the definitive agreements except by mutual written consent.

…

LOAN AND SECURITY AGREEMENT

** **

This Loan and Security Agreement (this “Agreement”) is executed by and among Big Digital Energy, Inc., a Delaware corporation (“Lender”), Texas Load House, LLC, a Texas limited liability company (“Borrower”) and 10NetZero, Inc., a Delaware corporation (“10NetZero”) effective as of July 14, 2026. Lender, Borrower and 10NetZero may be referred to herein collectively as the “Parties.” The Parties hereby agree as follows:

** **

Section 1. DEFINITIONS

When used in this Agreement, the capitalized terms set forth below shall have the definitions assigned to such terms below:

“Collateral” means all of 10NetZero’s right, title, and interest in and to the Membership Interests of Borrower, whether now owned or hereafter acquired, including all economic rights, distributions, proceeds, profits, certificates, securities, instruments, replacements, substitutions, and all proceeds of the foregoing, in each case to the fullest extent assignable or enforceable under the Operating Agreement and applicable law. Notwithstanding the foregoing, the Collateral is pledged solely to effectuate the Equity Slide Mechanic and the Full Wipe-Out provision described in Article 5 of the Operating Agreement, consistent with Section 2.3(f) of the binding Letter of Intent dated May 20, 2026 between Lender and 10NetZero (the “LOI”).

“Default” means any of the events specified in the section of this Agreement titled “Events of Default” that, with the passage of time or giving of notice or both, would constitute an Event of Default.

…

OPERATING AGREEMENT
OF

TEXAS LOAD HOUSE, LLC

** **

This Operating Agreement (“Operating Agreement” or “Agreement” as the case may be) of Texas Load House, LLC, a Texas limited liability company (the “Company”), effective as of May 28, 2026 (the “Effective Date”), is adopted by the Members of the Company and incorporates and implements the binding Letter of Intent dated May 20, 2026 between 10NetZero, Inc. (“10NZ”) and Big Digital Energy, Inc. (“BDE”) (the “LOI”). This Operating Agreement replaces in its entirety any prior operating agreement of the Company.

ARTICLE 1
GENERAL

1.1 * Formation; Name; Offices*. The Company has been formed as Texas Load House, LLC under the Texas Business Organizations Code (the “Code”). The principal office of the Company shall be in Fort Worth, Texas, or as subsequently designated by the Manager. The registered office of the Company required by the Code to be maintained in the State of Texas may be changed from time to time by the Managers.

1.2  Purpose. The purpose of the Company is to acquire, own, develop, finance, manage and operate the Cowtown Site and related assets and activities consistent with the LOI, and to engage in any lawful activity ancillary or related thereto.

1.3 * Duration of the Company*. The period of duration of the Company shall be perpetual unless it is earlier dissolved in accordance with this Operating Agreement or the Code.

1.4 * Definitions*.

…

JOINT MINING AGREEMENT

** **

THIS JOINT MINING AGREEMENT (this “Agreement”) is entered into effective April 27, 2026 (the “Effective Date”) by and between

Big Digital Energy, LLC**, **with its registered address at 2500 City West Blvd, Suite 150-138, Houston, TX 77042 (“Customer”), and

Big Digital Energy, Inc., with its registered address at 950 Railroad Ave. Midland, PA 15059 (“BGDE”)

(each of Customer and BGDE is hereinafter referred to individually as a “Party” and collectively as the “Parties”).

RECITALS

** **

WHEREAS, Customer owns certain cryptocurrency mining machines and appurtenant equipment, including Hosted Miners, as specified in Schedule B (the “Customer Equipment”);

WHEREAS, BGDE is principally engaged in data center management, cryptocurrency mining operations, and related services, and possesses the necessary facilities, expertise, and operational resources to manage data center infrastructure and operate cryptocurrency mining equipment;

WHEREAS, the Parties desire to collaborate in a joint mining arrangement, under which Customer will provide the Customer Equipment and BGDE will provide Data Center resources, hosting services, and operational management for the Customer Equipment and the Data Center in accordance with the terms of this Agreement;

…

REGISTRATION RIGHTS AGREEMENT

** **

This Registration Rights Agreement (this “Agreement”) is made and entered into as of June 30, 2026, between Big Digital Energy, Inc., a Delaware corporation (the “Company”), and each of the several purchasers signatory hereto (each such purchaser, a “Purchaser” and, collectively, the “Purchasers,” and together with the Company, the “Parties”). This Agreement is made pursuant to the Securities Purchase Agreement, dated as of the date hereof, between the Company and each Purchaser (the “Purchase Agreement”).

The Parties hereby agrees as follows:

	1.	Definitions.

Capitalized terms used and not otherwise defined herein that are defined in the Purchase Agreement shall have the meanings given such terms in the Purchase Agreement. As used in this Agreement, the following terms shall have the following meanings:

“Advice” has the meaning set forth in Section 6(c).

…